Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Lipocine (LPCN) over the last 13 years, with Q3 2025 value amounting to $26.3 million.

  • Lipocine's Cash & Current Investments fell 2676.68% to $26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.3 million, marking a year-over-year decrease of 2676.68%. This contributed to the annual value of $37.0 million for FY2024, which is 564.24% down from last year.
  • As of Q3 2025, Lipocine's Cash & Current Investments stood at $26.3 million, which was down 2676.68% from $29.5 million recorded in Q2 2025.
  • Lipocine's 5-year Cash & Current Investments high stood at $87.4 million for Q4 2021, and its period low was $26.3 million during Q3 2025.
  • In the last 5 years, Lipocine's Cash & Current Investments had a median value of $46.0 million in 2024 and averaged $52.3 million.
  • Per our database at Business Quant, Lipocine's Cash & Current Investments soared by 34537.58% in 2021 and then tumbled by 3617.83% in 2023.
  • Quarter analysis of 5 years shows Lipocine's Cash & Current Investments stood at $87.4 million in 2021, then fell by 29.72% to $61.5 million in 2022, then plummeted by 36.18% to $39.2 million in 2023, then decreased by 5.64% to $37.0 million in 2024, then fell by 28.95% to $26.3 million in 2025.
  • Its Cash & Current Investments was $26.3 million in Q3 2025, compared to $29.5 million in Q2 2025 and $36.1 million in Q1 2025.